At the time of publication, the innovative drug concept remains on the rise, with Lianhua Technology reaching its daily limit, and Ruizhi Pharmaceutical surging over 10%. Other companies, including Menovo, J&K Scientific, Sino Biopharmaceutical, Wanbang Pharmaceutical, and H&Y Pharmaceutical, have also experienced notable gains.